Le Kremlin Bicetre Cedex

• A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM 201 in Naïve-to-Tr … Not authorised
  2025-523820-26-00 5 Growth Hormone Deficiency (GHD)
• Stroke in childhood due to inflammatory narrowing of blood vessels: Treatment with steroids Pending
  2022-500631-36-00 5 Focal cerebral arteriopathy and childhood stroke Focal cerebral arteri
• E. coli Urinary Tract Infection Study Pending
  2023-509777-23-00 1 Bacterial urinary infection
• Extension Study of ACT-EARLY Pending
  2024-513676-18-00 5 Transthyretin Amyloidosis
• A Phase III study evaluating the efficacy of atezoliumab administration in addition to BCG (Bacillus Calmette-Guerin) for 1 year in patient … Pending
  2024-517621-54-00 5 High-risk non-muscle invasive bladder cancer (NMIBC) after transurethr
• CAN-GT Pending
  2024-519412-13-00 7 Canavan Disease
• “Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A Multicen … Pending
  2024-520414-21-00 5 Adult patients with a LVOS with large core within 9 hours of symptoms
• OTL-200 Long Term Insertional Oncogenesis Study Pending
  2025-522275-28-00 6 Metachromatic leukodystrophy
• A study testing the medicine angiotensin II in patients of 0–17 years with a life-threateningly low blood pressure Pending
  2025-523750-14-00 5 refractory hypotension in distributive shock
• A Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic effects of Subcutaneous Ocrelizumab in Childr … Pending
  2025-524164-37-00 4 Relapsing-Remitting Multiple Sclerosis (RRMS)
• STOP - Safety and efficacy of a STOPping strategy versus classical maintenance dose of JAK inhibitors in deep remission patients with ulcera … Pending
  2026-525643-32-00 6 ulcerative colitis
• A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in People With Hemophilia A Recruiting
  2025-522434-32-00 5 2026-07-01 Hemophilia A Without Inhibitors
• A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People with Hemophilia A Recruiting
  2025-522435-33-00 5 2026-06-17 Hemophilia A
• Is adding Cilostazol to nimodipine improving neurological outcome of patients with Aneurysmal Subarachnoid Hemorrhage? A randomized, double … Recruiting
  2024-516468-27-00 5 2026-04-07 Aneurysmal Subarachnoid Hemorrhage
• A study to assess efficacy and safety of empasiprubart versus IVIg in adults with CIDP ("emvigorate") Recruiting
  2024-520097-36-00 5 2026-01-07 Chronic inflammatory demyelinating polyneuropathy (CIDP)
• An open label clinical study to evaluate ANX005 (also known as tanruprubart) in participants with Guillain-Barré syndrome (FORWARD Study) Recruiting
  2025-522664-32-00 5 2025-12-10 Guillain Barre Syndrome
• A phase Ib, open-label, ascending dose study to assess safety, tolerability and pharmacokinetics of PIT565 in participants with rheumatoid a … Recruiting
  2024-520196-27-00 3 2025-10-01 Rheumatoid Arthritis
• A Study of Vosoritide in Children with Noonan Syndrome with Inadequate Growth During or After Human Growth Hormone Treatment Recruiting
  2024-515861-33-00 4 2025-03-25 Noonan Syndrome
• A study of anifrolumab in children and adolescents (5 to < 18 years old) with moderate to severe lupus to find the appropriate anifrolumab d … Recruiting
  2022-502289-25-00 5 2024-08-28 Moderate to Severe Active Systemic Lupus Erythematosus
• A study to find how well Dazodalibep works and how safe it is in participants with Sjôgren`s Syndrome Recruiting
  2023-503904-10-00 5 2024-06-07 Sjögren’s Syndrome With Moderate-to-severe Systemic Disease Activity
• Efficacy, safety, tolerability, and pharmacokinetics of risankizumab in pediatric subjects with active juvenile psoriatic arthritis Recruiting
  2023-506026-36-00 5 2024-04-29 Juvenile Psoriatic Arthritis
• Evaluation of the efficacy and safety of eneboparatide (AZP-3601) in patients with chronic hypoparathyroidism (CALYPSO) Recruiting
  2022-503126-12-01 5 2024-01-05 Hypoparathyroidism
• Clinical study to investigate the Efficacy and Safety of Encaleret Compared to Standard of Care treatment in patients with Autosomal Dominan … Recruiting
  2022-501398-38-00 5 2023-09-02 Autosomal Dominant Hypocalcemia Type 1 (ADH1)
• OPTIMAL CARE WITH GUSELKUMAB IN CROHN’S DISEASE Recruiting
  2025-524573-16-00 6 2026-06-11 Crohn's disease

Showing 1–24 of 103 trials